AN ACT TO AMEND TITLE 4 OF THE DELAWARE CODE RELATING TO THE REGULATION OF HEMP PRODUCTS.
HB401 creates a new regulatory framework in Title 4 of the Delaware Code for hemp-derived cannabinoid products (HDCPs), including products containing hemp-derived cannabinoids intended for human consumption. The bill authorizes the Office of the Marijuana Commissioner (OMC) to license retailers for off-premises sales only, while requiring age verification, 21-and-over access controls, sealed packaging, and limits on THC content per serving. It also bars on-site consumption and excludes certain businesses such as gas stations, grocery stores, and convenience stores from obtaining these retail licenses.
The bill further requires accredited laboratory testing for potency and contaminants, mandates certificates of analysis with QR-code or web-link access for consumers, and imposes detailed labeling rules designed to disclose THC content and warn against child appeal, pregnancy/breastfeeding use, and impairment. It sets product standards, authorizes enforcement actions including embargo, recall, destruction, and license suspension or revocation, and applies the rules to out-of-state manufacturers that import HDCPs into Delaware. The act also establishes a 6% excise tax on retail sales of HDCPs and requires monthly tax remittance and recordkeeping by retailers.
HB401 would add a comprehensive hemp-product licensing and enforcement scheme to Delaware law, primarily through new Chapter 14 of Title 4. It shifts oversight to the OMC, with support from the Division of Alcohol and Tobacco Enforcement and the Division of Revenue, and creates new statutory requirements for retailers, manufacturers, laboratories, and distributors of hemp-derived cannabinoid products. The bill also preempts local governments from imposing more restrictive minimum-distance rules for retail HDCP premises than those set by the General Assembly, and it provides a provisional licensing path for certain existing sellers and automatic coverage for existing retail marijuana store licensees. Because it imposes both a license fee and a new excise tax, it is subject to the constitutional three-fifths vote requirement noted in the synopsis.
The bill’s overall tone is regulatory rather than prohibitive: it seeks to legalize and structure the market for hemp-derived cannabinoid products while emphasizing consumer safety, youth access restrictions, and product testing. The synopsis frames the measure as a comprehensive public-safety and compliance bill, and the absence of recorded committee debate or votes suggests there is no documented public controversy in the provided materials. The bill appears designed to balance market access with stronger state control and tax collection.
The main points of potential contention are the new 6% excise tax, the $1,000 application fee, and the strict licensing and operational restrictions imposed on retailers and manufacturers. Businesses may object to the 21+ access requirement, the prohibition on gas stations, grocery stores, and convenience stores applying for licenses, the ban on on-site consumption, and the detailed testing and labeling mandates. Local governments could also be affected by the bill’s preemption of more restrictive spacing ordinances, while existing hemp-product sellers may focus on the provisional licensing criteria and the background-check disqualifications for applicants with certain criminal histories.